1. Su, Fei, Xiao, Ruowen, Chen, Rui, Guan, Quanlin, Feng, Maohui. 2023. WIPF1 promotes gastric cancer progression by regulating PI3K/Akt signaling in a myocardin-dependent manner. In iScience, 26, 108273. doi:10.1016/j.isci.2023.108273. https://pubmed.ncbi.nlm.nih.gov/38026208/
2. Zhang, Tao, Shen, Xiaopei, Liu, Rengyun, Bishop, Justin, Xing, Mingzhao. . Epigenetically upregulated WIPF1 plays a major role in BRAF V600E-promoted papillary thyroid cancer aggressiveness. In Oncotarget, 8, 900-914. doi:10.18632/oncotarget.13400. https://pubmed.ncbi.nlm.nih.gov/27863429/
3. Ramesh, N, Antón, I M, Martínez-Quiles, N, Geha, R S. . Waltzing with WASP. In Trends in cell biology, 9, 15-9. doi:. https://pubmed.ncbi.nlm.nih.gov/10087612/
4. Staub, Eike, Groene, Joern, Heinze, Maya, Buhr, Heinz-Johannes, Rosenthal, André. 2009. An expression module of WIPF1-coexpressed genes identifies patients with favorable prognosis in three tumor types. In Journal of molecular medicine (Berlin, Germany), 87, 633-44. doi:10.1007/s00109-009-0467-y. https://pubmed.ncbi.nlm.nih.gov/19399471/
5. Pan, Yu, Lu, Fengchun, Xiong, Ping, Pan, Minggui, Huang, Heguang. 2018. WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PDAC. In Journal of experimental & clinical cancer research : CR, 37, 167. doi:10.1186/s13046-018-0848-6. https://pubmed.ncbi.nlm.nih.gov/30041660/
6. Niehues, Tim, von Hardenberg, Sandra, Velleuer, Eunike. 2024. Rapid identification of primary atopic disorders (PAD) by a clinical landmark-guided, upfront use of genomic sequencing. In Allergologie select, 8, 304-323. doi:10.5414/ALX02520E. https://pubmed.ncbi.nlm.nih.gov/39381601/
7. Ding, Yinghe, Chu, Ling, Cao, Qingtai, Li, Xinyu, Zhuang, Quan. 2023. A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC. In BMC cancer, 23, 45. doi:10.1186/s12885-023-10532-y. https://pubmed.ncbi.nlm.nih.gov/36639648/
8. Alonso-Eiras, Jorge, Anton, Ines M. 2024. Multifaceted role of the actin-binding protein WIP: Promotor and inhibitor of tumor progression and dissemination. In Cytoskeleton (Hoboken, N.J.), 82, 186-196. doi:10.1002/cm.21935. https://pubmed.ncbi.nlm.nih.gov/39329352/